Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

France Banned AB Science Drug Studies Because of Side Effects
Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation.
Microparticle Platform
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.
The Role of CD8+ T Cells and Their Local Interaction with CD4+ T Cells in Myelin Oligodendrocyte Glycoprotein35-55-Induced Experimental Autoimmune Encephalomyelitis.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Pharmacology of HIV integrase inhibitors.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.
A manual of diseases of the nervous system
Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Biologically plausible and evidence-based risk intervals in immunization safety research.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders.
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.

Pages